Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A composition and drug technology, which can be used in drug combinations, pharmaceutical formulations, cardiovascular system diseases, etc., and can solve problems such as high cost and inappropriate operation.
Inactive Publication Date: 2009-09-02
吉林华康药业股份有限公司
View PDF0 Cites 2 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
However, if the coronary artery disease is scattered, it is not suitable for surgery. In addition, surgical treatment is more expensive than drug treatment, and drug maintenance treatment is still required after surgery.
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0033] Pseudo-ginsenoside GQ 60.0g
[0034] Propylene glycol 2000ml
[0035] Preparation process Take 60.0g of pseudo-ginsenoside GQ crude drug, add 2000ml of propylene glycol, heat and dissolve at 60-80°C, filter, pot, sterilize with damp heat at 121°C for 15min, sub-package, and make 1000 sticks, pH value is 4.0 -6.0.
Embodiment 2
[0037] Pseudo-ginsenoside GQ 0.2g
[0038] Propylene glycol 2000ml
[0039] Preparation process Take 0.2g of pseudo-ginsenoside GQ crude drug, add 2000ml of propylene glycol, heat and dissolve at 60-80°C, filter, pot, sterilize with damp heat at 121°C for 15min, sub-package, and make 1000 sticks, pH value is 4.0 -6.0.
Embodiment 3
[0041] Pseudo-ginsenoside GQ 200g
[0042] Propylene glycol 2000ml
[0043] Take 200g of pseudo-ginsenoside GQ crude drug, add 2000ml of propylene glycol, heat and dissolve at 60-80°C, filter, pot, sterilize with damp heat at 121°C for 15min, and pack to make 1000 tubes, with a pH value of 4.0-6.0.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention relates to a medical composition which belongs to a medical preparation. The medical composition is prepared from 0.01 percent to 10 percent (w/v) of pseudo-ginsenoside GQ and medical-acceptable solution, and the pH value is from 3.0 to 7.0. The invention has the advantages that the whole-body active allergic reaction of the pseudo-ginsenoside GQ injection liquid is negative, and the passive skin allergic test reaction of the pseudo-ginsenoside GQ is negative. The injection liquid is stable and has good clarity. The lyopilization powder is stable.
Description
technical field [0001] The invention belongs to a kind of pharmaceutical preparation. Background technique [0002] Myocardial ischemia (MI) is the result of an imbalance between the supply and demand of myocardial oxygen. On the one hand, due to insufficient coronary blood supply, on the other hand, excessive demand results in a lack of oxygen and nutrients in myocardial tissue, resulting in myocardial metabolism and dysfunction. Ischemia causes oxidative metabolic disorder, promotes anaerobic metabolism and leads to the accumulation of harmful products of anaerobic metabolism such as lactic acid, causing poisoning. Clinical manifestations of myocardial ischemia include angina pectoris, acute myocardial infarction, and asymptomatic myocardial ischemia with ischemic ECG changes. [0003] According to the "China Cardiovascular Disease Report 2006" report, China is in a period of economic transition, the national economy is developing rapidly, and people's lifestyles have un...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more